Real-time enrollment status for this pancreatic neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:33 AM UTC
| NCT Number | NCT05040360 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Neuroendocrine Tumors |
| Phase | PHASE2 |
| Target Enrollment | 141 participants |
| Active Locations | 446 sites in the US |
| Sponsor | SWOG Cancer Research Network |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of July 17, 2026: Clinical trial NCT05040360 is currently recruiting participants. This phase2 study for pancreatic neuroendocrine tumors is actively seeking new participants at 446 locations across the United States. The study is sponsored by SWOG Cancer Research Network. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05040360 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 446 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05040360 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.